United Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript

United Therapeutics (UTHR)

Q4 2011 Earnings Call

February 14, 2012, 9:00 a.m. ET

Executives

Martine Rothblatt - Founder, Chairman and CEO

Roger A. Jeffs - President, COO and Director

John M. Ferrari - CFO, Principal Accounting Officer and Treasurer

Andy Fisher - EVP

Analysts

Salveen Richter – Collins Stewart

Liana Moussatos – Wedbush Securities Inc.

Geoff Meacham – JPMorgan

Mark Schoenebaum (Omar) – ISI Group, Inc.

Robyn Karnauskas – Deutsche Bank AG

Philip Nadeau – Cowen and Company, LLC

Terence Flynn – Goldman Sachs

Robbie (Merofa) – Credit Suisse

Bret Holley – Oppenheimer & Co.

Matthew Kaplan (Susan) – Ladenburg Thalmann & Co.

Presentation

Operator

Compare to:
Previous Statements by UTHR
» United Therapeutics' CEO Discusses Q3 2011 Results - Earnings Call Transcript
» United Therapeutics Corporation Special Call
» United Therapeutics' CEO Discusses Q2 2011 Results - Earnings Call Transcript
» United Therapeutics Corporation Q4 2009 Earnings Call Transcript

Good morning. My name is Ben and I will be the conference operator today. At this time, I would like to welcome everyone to the United Therapeutics Corporation Fourth Quarter and annual 2011 financial results earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer session. [Operator Instructions].

Remarks today concerning United Therapeutics will include forward-looking statements, which represent United Therapeutics' expectations or beliefs regarding future events based on current assumptions. United Therapeutics cautions that such statements involve risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements.

Consequently, all such forward-looking statements are qualified by the cautionary language and risk factors set forth in United Therapeutics' periodic and other reports filed with the SEC. There can be no assurance that the actual results, events or developments referenced in such forward-looking statements will occur or be realized. United Therapeutics assumes no obligation to update these forward-looking statements to reflect actual results, changes and assumptions or changes in factors affecting such forward-looking statements. Thank you.

1 2 3 Next › Last »